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Ikuo Otsuka1,2, Masato Akiyama2,3, Osamu Shirakawa4, Satoshi Okazaki1, Yukihide Momozawa5, Yoichiro Kamatani2,6, Takeshi Izumi7,
Shusuke Numata8, Motonori Takahashi9, Shuken Boku1, Ichiro Sora1, Ken Yamamoto10, Yasuhiro Ueno9, Tatsushi Toda11,
Michiaki Kubo12 and Akitoyo Hishimoto1
Suicide is a significant public health problem worldwide, and several Asian countries including Japan have relatively high suicide
rates on a world scale. Twin, family, and adoption studies have suggested high heritability for suicide, but genetics lags behind due
to difficulty in obtaining samples from individuals who died by suicide, especially in non-European populations. In this study, we
carried out genome-wide association studies combining two independent datasets totaling 746 suicides and 14,049 non-suicide
controls in the Japanese population. Although we identified no genome-wide significant single-nucleotide polymorphisms (SNPs),
we demonstrated significant SNP-based heritability (35–48%; P < 0.001) for completed suicide by genomic restricted maximum-
likelihood analysis and a shared genetic risk between two datasets (Pbest= 2.7 × 10
−13) by polygenic risk score analysis. This study is
the first genome-wide association study for suicidal behavior in an East Asian population, and our results provided the evidence of
polygenic architecture underlying completed suicide.
Neuropsychopharmacology (2019) 44:2119–2124; https://doi.org/10.1038/s41386-019-0506-5
INTRODUCTION
Suicide is a significant public health problem that causes nearly
one million deaths worldwide each year [1]. In addition, several
Asian countries including Japan have relatively high suicide rates
on a world scale [2, 3].
There is evidence for high heritability in suicidal behavior, with
an estimated h2 of 30–50% based on twin, family, and adoption
studies in European populations [4]. To investigate the genetic
components of suicidal behavior, large-scale genetic studies
focusing on “completed suicide” should be crucial because other
suicidal behaviors (suicide ideation or attempt) vary in terms of
degree of lethality and suicidal intent, which may cause
heterogeneity [5]. However, due to the difficulty in obtaining
samples from individuals who died by suicide, few genome-wide
association studies (GWASs) have been reported (only European
populations) [6–9]. The largest case–control GWAS to date
included 317 suicides, and revealed no significant findings [7]. In
addition, no study has investigated single-nucleotide polymorph-
ism (SNP)-based heritability or polygenic effects for completed
suicide. Consequently, genetic insights into suicide lag behind
those of other mental problems, and no useful genetic biomarker
of suicide risk has been found.
On the other hand, previous studies have associated different
characteristics with suicidal behavior in different age groups; for
instance, more impulsive, aggressive, and novelty seeking
personality traits in the young, while heightened harm avoidance
and higher comorbidity rate of depression and physical diseases
were associated with increasing age of suicidal behavior [10–13].
Family studies have indicated strong familial transmission for
early-onset suicidal behavior [14–16]. These studies encourage
research focusing on the biological factors associated with age at
suicide.
Here, we first conducted genome-wide association analyses
using two independent datasets totaling ~746 suicides and 14,049
non-suicide controls in the Japanese population in order to
identify genetic variants affecting suicide risk (case–control study).
We then utilized these genome-wide SNP data to investigate SNP-
based heritability and polygenic effects for completed suicide.
Additionally, we also investigated individual variants and poly-
genicity affecting age at suicide (targeting only suicidal cohorts).
MATERIALS AND METHODS
Subjects
The entire study design and procedures were performed in
accordance with the Declaration of Helsinki. This study was
approved by the Ethics Committee for Genetic Studies of Kobe
University and RIKEN.
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Individuals who died by suicide
Autopsies on suicide victims were conducted at the Division of
Legal Medicine in the Department of Community Medicine and
Social Health Science at the Kobe University Graduate School of
Medicine. The verdict of “completed suicide” was made through
discussion with the Medical Examiner’s Office of the Hyogo
Prefecture and the Division of Legal Medicine in the Kobe
University Graduate School of Medicine [17]. In order to gather
background information on completed suicides, psychological
autopsy through their medical records and bereaved family
interviews were conducted by professional staff from the Medical
Examiner’s Office of the Hyogo Prefecture and the Division of
Legal Medicine in the Kobe University, where available.
Non-suicide controls
As non-suicide controls, we used genome-wide genotype data
from subjects in the Biobank Japan project who had been
genotyped as case subjects for non-psychiatric disorders and from
healthy volunteers of the Osaka-Midosuji Rotary Club and the
Pharma SNP consortium. The controls were not psychiatrically
evaluated [18–20].
Genotyping, QC, and imputation
We genotyped 434 individuals who died by suicide between June
1996 and July 2012 and 405 individuals who died by suicide
between August 2012 and February 2017 using Illumina
HumanOmniExpress and HumanOmniExpressExome BeadChips
for the first and second set, respectively. We obtained control data
genotyped with the same arrays (N= 7993 and 7136 for the first
and second set, respectively) (Table S1).
We performed quality control (QC) using PLINK 1.9 [21]. First, we
excluded SNPs with a call rate <0.98 and minor allele frequency
(MAF) <0.01, and those with P < 1.0 × 10−6 for Hardy–Weinberg
equilibrium (HWE) in controls. Related individuals were excluded
(PI_HAT ≥0.175). We then performed principal component analysis
(PCA), and excluded samples outside the Japanese main islands
cluster [22, 23]. The results of PCA are shown in Fig. S1. The final
datasets included 386 suicides and 7458 controls as the first set,
and 360 suicides and 6591 controls as the second set. After
estimating haplotypes using SHAPEIT2 (v2.r778) [24], we per-
formed genotype imputation by Minimac3 (1.0.13) [25] using ALL
samples in the 1000 Genomes Project phase 3v5 [26] as a
reference.
To investigate the X chromosome, we called genotypes using
GenomeStudio. First, we generated genoplots using only female
samples. After that, we added male samples to genoplots and
called genotypes. Genotypes called as heterozygotes were treated
as missing in male samples. For the genotyping QC, we excluded
SNPs with MAF <0.01 and SNP call rate <0.98 in either male or
female samples. We also excluded SNPs with P value for HWE
<1.0 × 10−6 in female samples. Haplotype phasing and imputation
were performed separately for males and females. Allelic dosages
were imputed from 0 to 2 in male samples under the assumption
of full dosage compensation. The pseudo-autosomal region was
excluded from the reference before imputation.
After imputation of autosomal and X chromosomes, we
included only SNPs with high imputation quality (r2 ≥ 0.7) and
MAF ≥0.01 (Fig. S2).
Association analysis and meta-analysis
For all GWASs identifying genetic variants affecting suicide risk
(case–control study; 746 suicides and 14,049 controls) and age at
suicide (only suicidal cohorts; 719 suicides), single variant
association tests were performed for common variants (MAF
≥0.01) using logistic regression and linear regression based on
Wald test implemented in the Rvtests software [27] with a
correction for the top 10 PCs as covariates. Meta-analysis was
performed with the METAL software [28] using a fixed-effects
model with inverse-variance weighted approach. The significance
level was set at P < 2.5 × 10−8 due to correction for multiple
comparison for two GWASs (case–control GWAS and GWAS for
age at suicide). P for heterogeneity between two analyses (first set
and second set) was calculated by Cochran’s Q test. Regional
association plots were generated using LocusZoom [29]. A QQ plot
for each GWAS is shown in Fig. S3.
Evaluation of previously implicated SNPs in prior GWAS of suicidal
behavior
Among variants that have previously been associated with suicidal
behavior (suicide ideation, suicide attempt, and suicide comple-
tion) in the published literature [7, 9, 30–36], we identified 26
variants with P < 1.0 × 10−6 in previous GWASs and MAF >0.01 in
JPT (Japanese in Tokyo, Japan) population (the 1000 Genomes
Project phase 3). We looked up the association of each of these
SNPs with the results from our case–control GWAS. Only the top
SNP in the same region in each reference was selected.
For a candidate SNP that was not directly genotyped or
imputed in our GWAS, we identified a proxy SNP (r2 > 0.8 in East
Asian samples of the 1000 Genomes Project phase 3) whenever
possible. For SNPs that reached P < 0.05, we determined whether
the direction of the association was consistent between the prior
and current studies.
Estimation of the proportion of the variance in completed suicide
explained by the genotyped SNPs (SNP-based heritability)
To assess SNP-based heritability (h2SNP), we used genome-wide
complex trait analysis (GCTA) [37] to generate genetic related-
ness matrices (GRMs) among 506,645 SNPs that passed QC in
both genotyped datasets, and then performed genomic
restricted maximum-likelihood (GREML) analysis. This assumed
prevalence rates of 0.1 and 0.5% for completed suicide,
considering the reported incidence of completed suicide in
Japan (Ministry of Health, Labor, and Welfare of Japan) [3] and
the estimates from previous papers [38–40]. We strictly
controlled the cryptic relatedness of the analyzed samples
using the –grm-cutoff option (threshold of 0.05) implemented
by GCTA, including 385 cases and 7409 controls for the first set,
and 357 cases and 6560 controls for the second set, respectively.
We then estimated SNP-based heritability using reml function
implemented by GCTA with top 10 PCs as covariates.
PRS analysis
Polygenic risk score (PRS) analyses were performed using PRSice
v1.23 [41]. The P threshold (Pt) for selecting “risk” SNPs was
sequentially set at 0.1, 0.2, 0.3, 0.4, and 0.5 without SNPs in the
major histocompatibility complex region. We then performed
linkage disequilibrium (LD) clumping (used by the default setting
of the software) to select the eligible SNPs for PRS. To calculate the
PRS, we analyzed two discovery/target sets, using the first set
(386 suicides and 7458 controls) as the discovery set and the
second set (360 suicides and 6591 controls) as the target set, and
vice versa. We included the top 10 PCs derived from each
genotyped dataset as covariates, respectively. The variance
explained for the PRS was estimated based on Nagelkerke’s R2
from a logistic regression model. For the analysis of polygenic
effects on age at suicide (first set, 366 suicides; second set,
353 suicides), we also applied the same procedure as the above to
the case–control GWAS datasets.
Pathway enrichment analysis
Using the results of a meta-analysis of the case–control GWAS
datasets, we ran PASCAL [42] for gene-based enrichment analysis
using 1077 gene sets, including KEGG [43], REACTOME [44], and
BIOCARTA (http://cgap.nci.nih.gov/Pathways/BioCarta_Pathways).
The significance level was set at χ2 P < 4.6 × 10−5 after Bonferroni
correction for 1077 tests.
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GWAS for risk of completed suicide
Sample characteristics are shown in Table S1. We performed a
meta-analysis of the case–control GWAS datasets for both suicides
and non-suicide controls (totaling 746 cases and 14,049 controls)
using 8,625,325 SNPs (λ genomic control (GC)= 1.07; Fig. S3a).
This analysis identified no genome-wide significant SNPs (Fig. S4),
although some loci, including SNPs on GRM1 and CTPS2, were
suggestive with Pmeta < 1.0 × 10
−6 (Table S2). In addition, we
looked up the 26 variants showing P < 1.0 × 10−6 in prior
European GWASs for suicidal behavior [7, 9, 30–36]. Among these,
rs7989250, reported in the recent UK Biobank GWAS for ordinal
suicidality, reached the threshold for our replication analysis (P <
0.05) with the same direction of allelic effect (Table S3). We ran
PASCAL [42] using our meta-GWAS to estimate the enrichments in
1077 gene sets, but no pathways were enriched at the Bonferroni
level of significance (Results for all tested 1077 pathways are listed
in an Excel spreadsheet that is included in the Supplementary
Material).
GREML analysis reveals high SNP-based heritability for completed
suicide
To investigate SNP-based heritability (h2SNP) for completed suicide,
we used GCTA [37] to GRMs using 506,645 directly genotyped
SNPs, and then estimated SNP-based heritability with GREML.
These analyses revealed significant SNP-based heritability in both
datasets (P < 0.001; Fig. 1). By combining the results, we estimated
that 35.9% and 48.3% of phenotypic variance in the two datasets
could be explained by SNPs with a prevalence of 0.1% and 0.5%,
respectively; this implies the underlying polygenic architecture
composed by numerous “risk” SNPs for completed suicide.
PRS analysis reveals polygenic effects for completed suicide
To investigate whether two independent datasets share genetic
components conferring the risk of completed suicide, we performed
PRS analyses by PRSice (v1.23) [41], setting the first set as the
discovery set and the second set as the target set, and vice versa.
The analyses demonstrated significant polygenic effects on
completed suicide (P < 0.001) when the SNPs were stratified by
P values, obtaining the most significant P values (Pbest= 2.7 × 10
−13)
with an inclusion threshold of Pt= 0.4 in each set, with explained
1.3–2.4% of the variance (Fig. 2 and Table S4). These results strongly
suggest shared genetic components for completed suicide between
the two datasets, providing additional evidence of polygenic
architecture underlying completed suicide.
GWAS for age at suicide
Age-divided sample characteristics focusing on psychological back-
ground information, comorbid severe physical diseases, and
distribution of age at suicide in both the first and second set of
our suicidal cohorts are shown in Table S5 and Fig. S5. We
performed GWAS for the age at completed suicide in each dataset
(only suicides with accurate age information available; N= 366 and
353 for the first and second set, respectively), and integrated these
results by fixed-effects meta-analysis. The meta-GWAS included
8,810,873 SNPs, and the genomic inflation factor suggested low
possibility of bias from population stratification and cryptic
relatedness (λ GC= 1.02; a QQ plot is shown in Fig. S3b). We
identified a novel suggestive locus on 7q11.23 in GTF2I repeat
domain containing 1 (GTF2IRD1) (top SNP rs73135307 G > C; P=
3.3 × 10−8, β=−12.3 years; Fig. 3, Table 1, Table S6, and Fig. S6)
without significant heterogeneity between the two datasets (Phet=
0.20). This means that the effect allele of rs73135307 (G allele) could
Fig. 1 Forest plot showing estimated SNP-based heritability in completed suicide. SNP-based heritability (h2SNP) was estimated with assumed
prevalence rates of 0.1 and 0.5% using the GREML method. Averages and 95% confidence intervals are shown
Fig. 2 Polygenic risk score (PRS) analysis of completed suicide. We
analyzed two discovery/target sets, using the first set as the
discovery set and the second set as the target set, and vice versa.
The P threshold (Pt) for selecting “risk” SNPs was sequentially set at
0.1, 0.2, 0.3, 0.4, and 0.5 without SNPs in the major histocompatibility
complex (MHC) region. The y-axis indicates the explained variation
(Nagelkerke’s R2)
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lead to 12.3 years younger of age at suicide in our suicidal cohort
compared to C allele. G allele frequency variation of rs73135307 in
divided groups based on age at suicide in the first and second set
are shown in Fig. S7. According to HaploReg (v4.1) [45], rs73135307
and the four variants in LD (r2 > 0.6 in East Asian samples of the 1000
Genomes Project [26]) with rs73135307 affect various histone
modifications (H3K4me1, H3K4me3, H3K27ac, and H3K9ac) in
various brain regions, including the hippocampus and dorsolateral
prefrontal cortex. However, neither nonsynonymous SNP nor
significant expression quantitative trait loci (eQTL) was found. Our
PRS analysis showed no significant polygenic effects on age at
suicide (Table S7).
DISCUSSION
Through the GWAS including 746 suicides in the Japanese
population, we demonstrated SNP-based heritability (35–48%)
and polygenic effects, indicating polygenic inheritance of
completed suicide. We also showed that the GTF2IRD1 locus is
suggestively associated with age at completed suicide.
Using the two case–control GWAS datasets, we estimated SNP-
based heritability with GREML and conducted PRS analyses.
Our GREML analysis revealed that completed suicide has significant
SNP-based heritability, with estimates of 35–48% in both individual
GWAS sets. We estimated SNP-based heritability using the GREML
method with two different prevalence rates (0.1 and 0.5%) assumed
from the reported incidence of completed suicide in Japan [3] and
the previous studies [38–40]. These estimates are qualified by the
difficulty of estimating the lifetime prevalence of completed suicide,
compared to those of “diseases,” presumably due to the influence of
historical and cultural contexts on the epidemiology of suicide,
along with other national/regional differences [46]. Moreover, our
PRS analyses demonstrated significant polygenic effects on
completed suicide, indicating that two independent cohorts of
suicides shared genetic components conferring suicide risk. Conse-
quently, to our knowledge, we provide the first evidence of SNP-
based heritability in completed suicide derived from case–control
GWAS dataset, other than from epidemiological data such as twin,
family, and adoption studies.
Due to the lack of well-designed epidemiological studies and
GWAS for suicidal behavior in Asia, this is the first study
demonstrating SNP-based heritability of suicide in an Asian
population. This is a major strength of the current study, since the
dearth of GWASs in non-European populations compared with the
abundance of European-descent studies is causing the disparity and
poor generalizability of genetic studies across populations [47]. The
Fig. 3 Regional plots of the top hit in the association results based on the meta-analysis of the first and second sets. Blue lines indicate the
recombination rate for East Asian samples of the 1000 Genomes Project phase 3. The y-axis is −log10(P value) of the SNPs and the x-axis is
chromosomal position (hg19). The linkage disequilibrium (r2) between the top and the remaining SNPs is indicated by color
Table 1. Top variant identified by meta-analysis of genome-wide association analyses of age at completed suicide
SNP Chra Positiona (bp) Genea (location) Effect allele (REF allele) Stage βb s.e. P value Phet
c
rs73135307 7 73,869,857 GTF2IRD1 (intronic) G (C) First set −9.84 2.97 9.17 × 10−4
Second set −15.6 3.39 4.15 × 10−6
Meta-analysis −12.3 2.23 3.25 × 10−8 0.20
Suggestive significance (P < 5.0 × 10−8) after meta-analysis of first and second set is shown in bold. Only top SNP in the same region is shown here. Full results
(P < 1.0 × 10−6) can be seen in Table S6
Chr chromosome, bp base pair, REF reference allele
aPosition and gene are based on Human Genome version 19 (hg19), build 37
bβ were calculated by linear regression based on Wald tests implemented in Rvtests software
cP for heterogeneity between two analyses (first set and second set) were calculated by Cochran’s Q test
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SNP-based heritability of completed suicide found in our analysis
dramatically exceeded the previous estimates from past GWASs of
suicide attempt in European populations, and further comparable to
twin heritability estimated by prior studies of European populations
despite SNP-based heritability estimates by GWASs usually explain-
ing roughly half of those based on twin modeling [48]. In order to
elucidate the reasons for the different levels of SNP-based
heritability estimated by previous GWASs for suicide attempt and
our GWAS, we should focus on the following points regarding SNP-
based heritability differences: (1) between suicide attempt and
suicide completion and (2) between Europeans and Asians. On the
other hand, significant high SNP-based heritability for completed
suicide shown here might be overestimated to some extent due to
residual population stratification (e.g., regional differences in Japan)
or the genetic effects of comorbid psychiatric disorders. Indeed,
genetic influences on suicidal behavior seem to be confounded by
genetic vulnerability for psychiatric disorders; for instance, a
previous twin study reported lower heritability (~17%) for suicidal
behavior after controlling for the inheritance of psychiatric disorders
[49]. Publicly available GWAS data focusing on psychiatric problems
in East Asian population are limited, which makes difficult to
perform replication of GWAS for suicidal behavior and in-depth
analyses (e.g., suicide GWAS divided into cases with and without
psychiatric disorders, or genetic correlation analysis with various
psychiatric disorders/conditions) using GWAS datasets from the
same Asian population. Since we have made our summary statistics
of GWAS publicly available, our data will enable the above analyses
in the future.
Our meta-analysis of two GWASs of age at completed suicide
identified a suggestive locus, intronic SNPs in the GTF2IRD1 gene
(top hit rs73135307, P= 3.3 × 10−8) at 7q11.23. This SNP and
variants in LD with the lead SNP are associated with various histone
modifications across brain regions related to suicide pathophysiol-
ogy [5], although none of those SNPs were nonsynonymous or
overlapped with eQTLs. GTF2IRD1 has been reported as one of the
promising genes for Williams syndrome (WS), particularly respon-
sible for neurodevelopmental abnormalities [50], which is known as
a risk factor for suicidal behavior [51]. While the typical social
phenotype of WS is characterized by optimistic personality, there is
also evidence of diametric characteristics in individuals with WS,
such as heightened anxiety, social relationship difficulties, and
higher prevalence of autism spectrum disorder (ASD) [52–54]. The
associations of GTF2IRD1 with anxiety and social impairment in WS
have been previously reported [53, 55]. In addition, various copy
number variations in 7q11.23 region have been strikingly implicated
in the genetic etiology of schizophrenia and ASD [56, 57], which are
associated with high risk of youth suicide [58, 59]. Focusing on this
chromosomal region by more detailed genome sequencing is
necessary to yield further insight into the genetic feature of suicide
in young people. Indeed, the aberrant personality traits, lower
comorbidity rate of depression and physical diseases, and familial
transmission previously linked with younger age at suicidal behavior
[10–16] indicated the possibility that future genetic studies for
suicide in young people may identify genetic clues.
It must be emphasized that our findings should be interpreted in
the context of several other limitations. First, although our sample
size was one of the largest ever for research on completed suicide,
larger sample sizes would be preferable in order to draw robust
conclusions regarding SNP-based heritability and polygenicity for
completed suicide, and to detect reliable genetic markers. In
particular, although we reported that the GTF2IRD1 locus is
suggestively associated with age at completed suicide, GWAS for
age at suicide here contained too small sample size (N= 719) and
replication studies are indeed required. Second, our study cohort
was restricted to only the Japanese population; thus, findings from
the present study might not be generalizable to other populations.
Third, the subjects we used non-suicide controls who had not been
psychiatrically screened. In addition, most of the controls had
various non-psychiatric disorders [18–20]. However, this approach
has been already applied in the previous GWAS [20] of which results
was replicable in other recent GWAS [60], supporting the reliability
of our results. Fourth, the biological interpretation of the significant
polygenic effects for completed suicide and the variants reported
here remains largely unknown due to lack of functional evidence
yielded by our pathway analysis and database searches, respectively.
In conclusion, we provided the first evidence of SNP-based
heritability and polygenic effects in completed suicide, and
polygenic effects in age at suicide.
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